vTv Therapeutics (VTVT) Appoints Deepa Prasad as President and CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- S&P 500, Nasdaq fall as chip stocks weaken; earnings and data in focus
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil prices dip but hold near highest in a month on Middle East tensions
- Citi sees Google, Meta and Amazon capex spending at over $800 billion in 2027
- UnitedHealth shares surge on strong earnings beat and guidance
vTv Therapeutics Announces Deepa Prasad as New President and CEO
October 20, 2021 9:00 AM EDTHIGH POINT, N.C., Oct. 20, 2021 /PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and psoriasis, today announced that Deepa Prasad will lead the company as President and Chief... More
